Seguridad de la Vacuna contra SARS-CoV-2 BNT162b2 en Pacientes Ancianos de Japón – Una evaluación preliminar y un Llamado a una Cuidadosa Farmacovigilancia
Abstract
Vaccines are efficacious, effective and safe measures to control COVID-19. Despite phase 3 and 4 studies, some concerns should be addressed in certain populations regarding its specific vaccine safety. One of them is the safety of the elderly. The majority of enrollees in clinical studies on COVID-19 vaccines have been young to middle-aged individuals, with few exceptions.
Downloads
Download data is not yet available.
Downloads
-
Vistas(Views): 215
- PDF (English) (Español (España)) Descargas(Downloads): 347
Published
2021-08-17
Issue
Section
Cartas al Editor